Drug firm Claris Lifesciences today reported a 31.09 per cent rise in its consolidated net profit to Rs 20.28 crore for the quarter ended June 30.
The company had posted a net profit of Rs 15.47 crore for the same period of the previous fiscal.
Consolidated total income from operations of the company rose to Rs 191.94 crore during the quarter as against Rs 156.58 crore for the same quarter, a year ago.
Shares of Claris Lifesciences today closed at Rs 220.60 per scrip on BSE, down 4.13 per cent.